Piper Jaffray Companies Comments on Agilent Technologies Inc’s FY2019 Earnings (NYSE:A)

Share on StockTwits

Agilent Technologies Inc (NYSE:A) – Investment analysts at Piper Jaffray Companies increased their FY2019 earnings per share estimates for Agilent Technologies in a research note issued on Wednesday, August 14th. Piper Jaffray Companies analyst W. Quirk now anticipates that the medical research company will post earnings per share of $3.08 for the year, up from their previous estimate of $3.07. Piper Jaffray Companies has a “Overweight” rating and a $86.00 price target on the stock. Piper Jaffray Companies also issued estimates for Agilent Technologies’ Q4 2019 earnings at $0.86 EPS, Q1 2020 earnings at $0.84 EPS, Q2 2020 earnings at $0.80 EPS, Q3 2020 earnings at $0.86 EPS, Q4 2020 earnings at $0.91 EPS, FY2020 earnings at $3.41 EPS and FY2021 earnings at $3.82 EPS.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 14th. The medical research company reported $0.76 EPS for the quarter, beating the Zacks’ consensus estimate of $0.72 by $0.04. Agilent Technologies had a return on equity of 20.00% and a net margin of 21.06%. The company had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.24 billion. During the same quarter in the previous year, the business earned $0.67 earnings per share. The company’s revenue for the quarter was up 5.6% on a year-over-year basis.

A number of other research firms also recently commented on A. Needham & Company LLC lifted their target price on Agilent Technologies to $92.00 and gave the company a “buy” rating in a research report on Monday. Wolfe Research assumed coverage on Agilent Technologies in a report on Thursday, May 30th. They issued a “peer perform” rating on the stock. Barclays downgraded Agilent Technologies from an “overweight” rating to an “equal weight” rating and cut their price objective for the company from $86.00 to $78.00 in a report on Monday, July 15th. Deutsche Bank cut their price objective on Agilent Technologies from $90.00 to $85.00 and set a “buy” rating on the stock in a report on Wednesday, May 15th. Finally, Zacks Investment Research downgraded Agilent Technologies from a “buy” rating to a “hold” rating and set a $75.00 price objective on the stock. in a report on Monday. Six research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $84.77.

NYSE:A opened at $71.12 on Monday. Agilent Technologies has a 52 week low of $61.01 and a 52 week high of $82.27. The company has a quick ratio of 1.72, a current ratio of 2.13 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $22.46 billion, a P/E ratio of 25.49, a P/E/G ratio of 1.96 and a beta of 1.41. The stock’s fifty day moving average is $70.51 and its two-hundred day moving average is $74.54.

Several hedge funds have recently bought and sold shares of A. Invesco Ltd. raised its holdings in shares of Agilent Technologies by 478.4% in the 2nd quarter. Invesco Ltd. now owns 9,230,526 shares of the medical research company’s stock valued at $689,243,000 after buying an additional 7,634,621 shares during the period. Nuveen Asset Management LLC raised its holdings in shares of Agilent Technologies by 1,283.4% in the 2nd quarter. Nuveen Asset Management LLC now owns 1,792,959 shares of the medical research company’s stock valued at $133,880,000 after buying an additional 1,663,354 shares during the period. Findlay Park Partners LLP raised its holdings in shares of Agilent Technologies by 51.9% in the 2nd quarter. Findlay Park Partners LLP now owns 4,500,000 shares of the medical research company’s stock valued at $336,015,000 after buying an additional 1,538,234 shares during the period. D. E. Shaw & Co. Inc. raised its holdings in shares of Agilent Technologies by 40.8% in the 2nd quarter. D. E. Shaw & Co. Inc. now owns 4,910,795 shares of the medical research company’s stock valued at $366,689,000 after buying an additional 1,423,567 shares during the period. Finally, American Century Companies Inc. grew its stake in Agilent Technologies by 20.6% during the 1st quarter. American Century Companies Inc. now owns 4,928,415 shares of the medical research company’s stock worth $396,146,000 after purchasing an additional 840,850 shares in the last quarter.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

See Also: What are defining characteristics of a correction?

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

VANGUARD SCOTTS/VANGUARD RUSSELL 20  Shares Acquired by Wells Fargo & Company MN
VANGUARD SCOTTS/VANGUARD RUSSELL 20 Shares Acquired by Wells Fargo & Company MN
$1.41 EPS Expected for Burlington Stores Inc  This Quarter
$1.41 EPS Expected for Burlington Stores Inc This Quarter
$1.79 Billion in Sales Expected for Burlington Stores Inc  This Quarter
$1.79 Billion in Sales Expected for Burlington Stores Inc This Quarter
Public Employees Retirement System of Ohio Has $2.94 Million Holdings in Wyndham Destinations
Public Employees Retirement System of Ohio Has $2.94 Million Holdings in Wyndham Destinations
Public Employees Retirement System of Ohio Buys Shares of 34,182 Guardant Health Inc
Public Employees Retirement System of Ohio Buys Shares of 34,182 Guardant Health Inc
Public Employees Retirement System of Ohio Grows Position in Empire State Realty Trust Inc
Public Employees Retirement System of Ohio Grows Position in Empire State Realty Trust Inc


© 2006-2019 Ticker Report